Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Mizuho 

Quest Diagnostics Inc. diskutieren

Quest Diagnostics Inc.

WKN: 904533 / Symbol: DGX / Name: Quest Diagnostcs / Aktie / Anbieter & Dienstleistungen / Large Cap /

175,70 €
0,40 %

Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Ratings data for DGX provided by MarketBeat

Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Quest Diagnostics (DGX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Ratings data for DGX provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 195,85
Veränderung
Endet am 22.04.27

Quest Diagnostics (DGX) had its price target raised by Barclays PLC from $225.00 to $230.00. They now have an "overweight" rating on the stock.
Ratings data for DGX provided by MarketBeat